Intelligence IAMay 15, 2026Intelligence IA
Article
TuHURA Biosciences, an immuno-oncology company, released Q1 2026 financial results.
The company is developing novel therapies to overcome resistance to cancer immunotherapy.
Redaction Data Cube AISource: PR Newswire
01
Brief source
TuHURA Biosciences, an immuno-oncology company, released Q1 2026 financial results. The company is developing novel therapies to overcome resistance to cancer immunotherapy.